Armistice Capital, LLC Portage Biotech Inc. Transaction History
Armistice Capital, LLC
- $7.34 Billion
- Q1 2024
A detailed history of Armistice Capital, LLC transactions in Portage Biotech Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 1,665,885 shares of PRTG stock, worth $366,494. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,665,885
Previous 1,876,105
11.21%
Holding current value
$366,494
Previous $3.41 Million
72.7%
% of portfolio
0.01%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding PRTG
# of Institutions
27Shares Held
2.16MCall Options Held
0Put Options Held
0-
Bison Wealth, LLC213KShares$46,9470.02% of portfolio
-
Peak6 Investments LLC Chicago, IL55.3KShares$12,1570.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny32.8KShares$7,2210.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny31.7KShares$6,9650.0% of portfolio
-
Black Rock Inc. New York, NY31.3KShares$6,8800.0% of portfolio
About PORTAGE BIOTECH INC.
- Ticker PRTG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,943,700
- Market Cap $3.73M
- Description
- Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...